Monoclonal gammopathy of undetermined significance: a consensus statement
Open Access
- 9 June 2010
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 150 (1), 28-38
- https://doi.org/10.1111/j.1365-2141.2010.08207.x
Abstract
On February 25, 2009, a panel of international experts on plasma cell dyscrasia and skeletal disease met to discuss monoclonal gammopathy of undetermined significance (MGUS). This non‐malignant B‐cell disorder is the most common plasma cell dyscrasia and is associated with an increased risk of developing serious B‐cell disorders. Individuals with MGUS also have an increased risk of osteoporosis and osteopenia associated with an increased likelihood of developing fractures especially in the vertebral column, peripheral neuropathy and thromboembolic events. The goal of the meeting was to develop a consensus statement regarding the appropriate tests to screen, evaluate and follow‐up patients with MGUS. The panel also addressed the identification and treatment of MGUS‐related skeletal problems, thromboembolic events and neurological complications. The following consensus statement outlines the conclusions and marks the first time that a consensus statement for the screening and treatment of MGUS has been clearly stated.Keywords
This publication has 74 references indexed in Scilit:
- A Randomized Trial of Vertebroplasty for Osteoporotic Spinal FracturesNew England Journal of Medicine, 2009
- A Randomized Trial of Vertebroplasty for Painful Osteoporotic Vertebral FracturesNew England Journal of Medicine, 2009
- Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significanceBlood, 2009
- Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health StudyBlood, 2009
- A monoclonal gammopathy precedes multiple myeloma in most patientsBlood, 2009
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myelomaBlood, 2008
- Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-l-carnitineEuropean Journal Of Cancer, 2005
- Osteoporosis and Fracture Risk in Women of Different Ethnic GroupsJournal of Bone and Mineral Research, 2005
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004